HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scharnhorst, V. Articles by Jochemsen, A. G. Search for Related Content PubMed PubMed Citation Articles by Scharnhorst, V. Articles by Jochemsen, A. G. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 33, 23456-23462, August 13, 1999

Internal Translation Initiation Generates Novel WT1 Protein Isoforms with Distinct Biological Properties

From the Laboratory of Molecular Carcinogenesis and Centre for Biomedical Genetics, Leiden University Medical Center, P.O. Box 9503, 2300 RA Leiden, The Netherlands

The Wilms' tumor 1 gene, WT1, is homozygously mutated in a subset of Wilms' tumors. Heterozygous mutations in WT1 give rise to congenital anomalies. During embryogenesis, WT1 is expressed mainly in the kidneys, uterus, and testes.

Alternative splicing of the WT1 mRNA results in synthesis of four main WT1 protein isoforms with molecular masses of 52-54 kDa. In addition, translation initiation at a CUG upstream of the initiator AUG generates four larger WT1 proteins of 60-62 kDa.

We describe here the existence of novel WT1 isoforms and demonstrate that they are derived from translation initiation at the second in-frame AUG of the WT1 mRNA. These N-terminally truncated WT1 proteins of 36-38 kDa can be detected in several cell lines, mouse testes, and Wilms' tumor specimens. They can bind to DNA and direct transcription from reporter constructs. The shorter WT1 protein lacking the two splice inserts has a greater transcription activation potential than the corresponding main WT1 protein isoform but shows no transcription repression potential. Overexpression of full-length or N-terminally truncated WT1 efficiently induces apoptosis. These data show that additional WT1 isoforms with distinct transcription-regulatory properties exist, which further increases the complexity of WT1 expression and activity.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. K.-H. Kim, T. J. McGarry, P. O Broin, J. M. Flatow, A. A.-J. Golden, and J. D. Licht An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 PNAS, July 7, 2009; 106(27): 11154 - 11159. [Abstract] [Full Text] [PDF]

				H.-S. Kim, M. S. Kim, A. L. Hancock, J. C. P. Harper, J. Y. Park, G. Poy, A. O. Perantoni, M. Cam, K. Malik, and S. B. Lee Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development J. Biol. Chem., June 1, 2007; 282(22): 16278 - 16287. [Abstract] [Full Text] [PDF]

				K. M. Kirschner, N. Wagner, K.-D. Wagner, S. Wellmann, and H. Scholz The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the {alpha}4integrin Gene J. Biol. Chem., October 20, 2006; 281(42): 31930 - 31939. [Abstract] [Full Text] [PDF]

				A. Hossain, M. Nixon, M. T. Kuo, and G. F. Saunders N-terminally Truncated WT1 Protein with Oncogenic Properties Overexpressed in Leukemia J. Biol. Chem., September 22, 2006; 281(38): 28122 - 28130. [Abstract] [Full Text] [PDF]

				N. Wagner, K.-D. Wagner, H. Scholz, K. M. Kirschner, and A. Schedl Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1 Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R779 - R787. [Abstract] [Full Text] [PDF]

				M. K. Rao, J. Pham, J. S. Imam, J. A. MacLean, D. Murali, Y. Furuta, A. P. Sinha-Hikim, and M. F. Wilkinson Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis Genes & Dev., January 15, 2006; 20(2): 147 - 152. [Abstract] [Full Text] [PDF]

				N. Wagner, K.-D. Wagner, A. Hammes, K. M. Kirschner, V. P. Vidal, A. Schedl, and H. Scholz A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system Development, March 15, 2005; 132(6): 1327 - 1336. [Abstract] [Full Text] [PDF]

				H. Scholz and K. M. Kirschner A Role for the Wilms' Tumor Protein WT1 in Organ Development Physiology, February 1, 2005; 20(1): 54 - 59. [Abstract] [Full Text] [PDF]

				L. Shahrabani-Gargir, T. K. Pandita, and H. Werner Ataxia-Telangiectasia Mutated Gene Controls Insulin-Like Growth Factor I Receptor Gene Expression in a Deoxyribonucleic Acid Damage Response Pathway via Mechanisms Involving Zinc-Finger Transcription Factors Sp1 and WT1 Endocrinology, December 1, 2004; 145(12): 5679 - 5687. [Abstract] [Full Text] [PDF]

				J. Renshaw, R. M. Orr, M. I. Walton, R. te Poele, R. D. Williams, E. V. Wancewicz, B. P. Monia, P. Workman, and K. Pritchard-Jones Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival Mol. Cancer Ther., November 1, 2004; 3(11): 1467 - 1484. [Abstract] [Full Text] [PDF]

				A. R. Dallosso, A. L. Hancock, K. W. Brown, A. C. Williams, S. Jackson, and K. Malik Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours Hum. Mol. Genet., February 15, 2004; 13(4): 405 - 415. [Abstract] [Full Text] [PDF]

				M. T. Discenza and J. Pelletier Insights into the physiological role of WT1 from studies of genetically modified mice Physiol Genomics, February 13, 2004; 16(3): 287 - 300. [Abstract] [Full Text] [PDF]

				C. E. Patek, S. Fleming, C. G. Miles, C. O. Bellamy, M. Ladomery, L. Spraggon, J. Mullins, N. D. Hastie, and M. L. Hooper Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis Hum. Mol. Genet., September 15, 2003; 12(18): 2379 - 2394. [Abstract] [Full Text] [PDF]

				K.-D. Wagner, N. Wagner, and A. Schedl The complex life of WT1 J. Cell Sci., May 1, 2003; 116(9): 1653 - 1658. [Abstract] [Full Text] [PDF]

				T. H. Lee, S. Lwu, J. Kim, and J. Pelletier Inhibition of Wilms Tumor 1 Transactivation by Bone Marrow Zinc Finger 2, a Novel Transcriptional Repressor J. Biol. Chem., November 15, 2002; 277(47): 44826 - 44837. [Abstract] [Full Text] [PDF]

				S. E. Damon, S. R. Plymate, J. M. Carroll, C. C. Sprenger, C. Dechsukhum, J. L. Ware, and C. T. Roberts Jr. Transcriptional Regulation of Insulin-Like Growth Factor-I Receptor Gene Expression in Prostate Cancer Cells Endocrinology, January 1, 2001; 142(1): 21 - 27. [Abstract] [Full Text] [PDF]

				C. MROWKA and A. SCHEDL Wilms' Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features J. Am. Soc. Nephrol., November 1, 2000; 11(90002): S106 - S115. [Abstract] [Full Text] [PDF]

				D. Baudry, M. Hamelin, M.-O. Cabanis, J.-C. Fournet, M.-F. Tournade, S. Sarnacki, C. Junien, and C. Jeanpierre WT1 Splicing Alterations in Wilms' Tumors Clin. Cancer Res., October 1, 2000; 6(10): 3957 - 3965. [Abstract] [Full Text]

				N. A. Little, N. D. Hastie, and R. C. Davies Identification of WTAP, a novel Wilms' tumour 1-associating protein Hum. Mol. Genet., September 1, 2000; 9(15): 2231 - 2239. [Abstract] [Full Text] [PDF]

				A. Gaiger, V. Reese, M. L. Disis, and M. A. Cheever Immunity to WT1 in the animal model and in patients with acute myeloid leukemia Blood, August 15, 2000; 96(4): 1480 - 1489. [Abstract] [Full Text] [PDF]

				V. Scharnhorst, P. Dekker, A. J. van der Eb, and A. G. Jochemsen Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions J. Biol. Chem., March 31, 2000; 275(14): 10202 - 10211. [Abstract] [Full Text] [PDF]

				R. Stad, Y. F. M. Ramos, N. Little, S. Grivell, J. Attema, A. J. van der Eb, and A. G. Jochemsen Hdmx Stabilizes Mdm2 and p53 J. Biol. Chem., September 1, 2000; 275(36): 28039 - 28044. [Abstract] [Full Text] [PDF]

				C. Husberg, P. Murphy, E. Martin, and A.-B. Kolsto Two Domains of the Human bZIP Transcription Factor TCF11 Are Necessary for Transactivation J. Biol. Chem., May 18, 2001; 276(21): 17641 - 17652. [Abstract] [Full Text] [PDF]

				S. Saburi, D. Nadano, T. O. Akama, K. Hirama, K. Yamanouchi, K. Naito, H. Tojo, C. Tachi, and M. N. Fukuda The Trophinin Gene Encodes a Novel Group of MAGE Proteins, Magphinins, and Regulates Cell Proliferation during Gametogenesis in the Mouse J. Biol. Chem., December 21, 2001; 276(52): 49378 - 49389. [Abstract] [Full Text] [PDF]